tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Moleculin Biotech Inc

MBRX
Add to Watchlist
0.398USD
-0.622-60.96%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.12MMarket Cap
LossP/E TTM

Moleculin Biotech Inc

0.398
-0.622-60.96%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

MBRX Financials

See Moleculin Biotech Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Moleculin Biotech Inc Earnings Date

Latest Release
May 16, 2026
EPS / Forecast
-3.54/-1.66
Revenue / Forecast
0.00/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-28.42
84.97%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-414.27%-3.54
1947.51%6.90
-496.89%-17.02
71.02%-0.49
65.82%-0.69
92.66%-0.37
-1.04%-2.85
43.76%-1.70
51.20%-2.02
-43.42%-5.09
---2.82
---3.02
---4.13
---3.55
---11.67
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-127.00%-14.61M
920.83%15.45M
-139.79%-25.40M
-76.89%-7.64M
-29.50%-6.44M
81.67%-1.88M
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
-54.49%-6.87M
-7.05%-2.83M
-28.98%-4.38M
58.03%-4.24M
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-32.49%-7.87M
-13.40%-7.53M
17.22%-5.91M
7.52%-5.72M
10.99%-5.94M
25.52%-6.64M
-19.98%-7.13M
3.53%-6.18M
20.07%-6.68M
-26.55%-8.92M
34.53%-5.95M
13.76%-6.41M
-18.09%-8.35M
-35.41%-7.05M
-47.54%-9.08M
-34.75%-7.43M
-16.20%-7.07M
-48.93%-5.21M
-0.10%-6.16M
-9.59%-5.52M
Net Profit
-127.00%-14.61M
920.83%15.45M
-139.79%-25.40M
-76.89%-7.64M
-29.50%-6.44M
81.67%-1.88M
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
-54.49%-6.87M
-7.05%-2.83M
-28.98%-4.38M
58.03%-4.24M
Balance Sheet
Current assets
17.36%10.96M
86.48%9.69M
-32.06%7.88M
-33.90%9.08M
-50.73%9.34M
-80.23%5.19M
-57.95%11.61M
-61.19%13.73M
-51.75%18.96M
-42.38%26.27M
-48.40%27.60M
-42.30%35.38M
-41.59%39.29M
-37.11%45.60M
-30.59%53.49M
-25.07%61.32M
-23.58%67.26M
321.54%72.50M
405.38%77.07M
314.38%81.84M
Total current liabilities
15.46%7.96M
27.90%6.85M
1.59%5.68M
37.71%7.91M
27.51%6.90M
-21.36%5.36M
43.85%5.59M
-12.33%5.75M
7.47%5.41M
41.42%6.81M
-38.89%3.89M
11.86%6.55M
4.10%5.03M
33.05%4.82M
74.02%6.36M
74.90%5.86M
5.59%4.83M
24.04%3.62M
6.34%3.66M
-10.40%3.35M
Total assets
11.18%23.36M
30.73%22.13M
-13.00%20.35M
-15.57%21.59M
-31.88%21.01M
-55.71%16.93M
-40.81%23.39M
-45.72%25.57M
-39.59%30.84M
-33.45%38.22M
-39.54%39.52M
-35.68%47.12M
-35.20%51.06M
-31.71%57.42M
-26.30%65.37M
-21.68%73.25M
-21.03%78.80M
189.66%84.09M
226.78%88.70M
198.07%93.53M
Total liabilities
-60.99%8.18M
-34.95%7.12M
197.03%47.27M
265.41%28.76M
126.52%20.97M
-9.86%10.95M
262.94%15.91M
14.94%7.87M
72.15%9.26M
132.15%12.14M
-36.95%4.38M
-0.71%6.85M
-12.35%5.38M
2.63%5.23M
-6.56%6.96M
-21.94%6.90M
-45.54%6.14M
-54.78%5.10M
-41.29%7.44M
-43.91%8.83M
Total equity
36050.00%15.18M
150.98%15.01M
-459.94%-26.92M
-140.47%-7.17M
-99.81%42.00K
-77.07%5.98M
-78.72%7.48M
-56.03%17.70M
-52.75%21.59M
-50.04%26.07M
-39.85%35.14M
-39.32%40.27M
-37.13%45.68M
-33.93%52.19M
-28.11%58.42M
-21.65%66.36M
-17.91%72.67M
344.78%78.99M
461.69%81.26M
441.94%84.70M
Cash Flow Statement
Net operating income
-33.90%-6.11M
-5.57%-5.37M
-18.16%-7.22M
6.17%-5.58M
32.05%-4.56M
5.99%-5.08M
19.04%-6.11M
-16.06%-5.95M
-11.63%-6.72M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-70.41%-7.26M
-76.70%-7.58M
-17.99%-8.00M
-32.59%-4.80M
-36.30%-4.26M
20.18%-4.29M
-37.46%-6.78M
Net investment
--0.00
--0.00
--0.00
100.00%0.00
--0.00
100.00%0.00
100.00%0.00
13.33%-13.00K
----
---81.00K
---28.00K
75.41%-15.00K
100.00%0.00
100.00%0.00
--0.00
---61.00K
---6.00K
-35.71%-19.00K
100.00%0.00
100.00%0.00
Net financing
-4.84%7.61M
748600.00%7.49M
36.83%6.38M
21792.00%5.42M
--8.00M
-99.98%1.00K
116575.00%4.66M
-151.02%-25.00K
-100.00%0.00
--4.46M
63.64%-4.00K
508.33%49.00K
--141.00K
--0.00
54.17%-11.00K
---12.00K
-100.00%0.00
-100.00%0.00
-101.36%-24.00K
-100.00%0.00

FAQs

What are the current assets of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its current assets were 9.69M, with a year-on-year change of 86.48.

What are the total assets of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its total assets of Moleculin Biotech Inc were 22.13M, with a year-on-year change of 30.73.

What are the total liabilities of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its total liabilities of Moleculin Biotech Inc were 7.12M, with a year-on-year change of 24.54.

What is the total equity of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its total equity of Moleculin Biotech Inc was 15.01M, with a year-on-year change of 33.89.

What is the net operating income of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its net operating income of Moleculin Biotech Inc was -25.10M, with a year-on-year change of 5.77.

What is the net financing of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its net financing of Moleculin Biotech Inc was 27.28M, with a year-on-year change of 488.65.

What is the Earnings Per Share (EPS) of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -28.42, with a year-on-year change of 84.97.

What is the net income of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its net income was -33.66M, with a year-on-year change of -29.24.

What is the Return on Equity (ROE) of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its Return on Equity (ROE) was -256.84, with a year-on-year change of -83.80.

What is the Return on Assets (ROA) of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its Return on Assets (ROA) was -171.88, with a year-on-year change of -81.93.

What is the operating profit of Moleculin Biotech Inc?

According to Moleculin Biotech Inc's FY2025 earnings report, its operating profit was -25.10M, with a year-on-year change of 5.77.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy